Cart
sales@molnova.com
ERG240
CAS No. 1415683-79-2
ERG240( —— )
Catalog No. M36020 CAS No. 1415683-79-2
ERG240 is an inhibitor of branched-chain amino acid aminotransferase 1 (BCAT1). ERG240 can be used for the research of rheumatoid arthritis, cancer, and bone disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 58 | In Stock |
|
| 10MG | 84 | In Stock |
|
| 25MG | 140 | In Stock |
|
| 50MG | 222 | In Stock |
|
| 100MG | 328 | In Stock |
|
| 200MG | 488 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameERG240
-
NoteResearch use only, not for human use.
-
Brief DescriptionERG240 is an inhibitor of branched-chain amino acid aminotransferase 1 (BCAT1). ERG240 can be used for the research of rheumatoid arthritis, cancer, and bone disease.
-
DescriptionEGR240 is a branched-chain amino acid aminotransferase 1 (BCAT1) inhibitor. EGR240 can be used for the research of cancer, rheumatoid arthritis, and bone disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1415683-79-2
-
Formula Weight166.15
-
Molecular FormulaC7H11NaO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (601.87 mM; Ultrasonic )H2O : 100 mg/mL (601.87 mM; Ultrasonic)
-
SMILESCC(C(C)CCC([O-])=O)=O.[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Papathanassiu, et al. Methods for treatment of cancer, inflammatory autoimmune disorders and bone diseases using branched-chain amino acid aminotransferase-1 (BCAT1) inhibitors. Patent. WO2012173987.
molnova catalog
related products
-
Tuberostemonine D
Tuberostemonine D, an alkaloid obtained, can be obtained from the root of Stemona tuberosa.
-
L-DAB HBR
L-DAB HBR is an inhibitor of GABA transaminase ?(IC50 > 500 μM).
-
Carbazochrome
Carbazochrome?is an antihemorrhagic, or hemostatic, agent that will cease blood flow by causing the aggregation and adhesion of platelets in the blood to form a platelet plug, ceasing blood flow from an open wound.
